SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-147476
Filing Date
2020-05-20
Accepted
2020-05-20 17:12:19
Documents
13
Period of Report
2020-05-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d929990d8k.htm   iXBRL 8-K 60710
  Complete submission text file 0001193125-20-147476.txt   223710

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amgn-20200519.xsd EX-101.SCH 4547
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20200519_def.xml EX-101.DEF 13773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20200519_lab.xml EX-101.LAB 22821
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20200519_pre.xml EX-101.PRE 14742
15 EXTRACTED XBRL INSTANCE DOCUMENT d929990d8k_htm.xml XML 6351
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 20898956
SIC: 2836 Biological Products, (No Diagnostic Substances)